Tokyo Tape
Sign in
← Oncolys BioPharma

Quarterly report · Q2

4588.TEDINET S100RJIV
Period2023-01-01 → 2023-06-30
Filed2023-08-04
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥63m2023-01-01 → 2023-06-30StandaloneNet sales
Revenue¥976m2022-01-01 → 2022-12-31StandaloneNet sales (5-year summary)
Revenue¥426m2022-01-01 → 2022-06-30StandaloneNet sales
Operating income−¥901m2023-01-01 → 2023-06-30StandaloneOperating income
Operating income−¥659m2022-01-01 → 2022-06-30StandaloneOperating income
Ordinary income−¥867m2023-01-01 → 2023-06-30StandaloneOrdinary income
Ordinary income−¥1.2bn2022-01-01 → 2022-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥591m2022-01-01 → 2022-06-30StandaloneOrdinary income
Profit before tax−¥867m2023-01-01 → 2023-06-30StandaloneIncome before income taxes
Profit before tax−¥569m2022-01-01 → 2022-06-30StandaloneIncome before income taxes
Net income−¥869m2023-01-01 → 2023-06-30StandaloneProfit loss
Net income−¥1.1bn2022-01-01 → 2022-12-31StandaloneNet income loss (5-year summary)
Net income−¥571m2022-01-01 → 2022-06-30StandaloneProfit loss
Total assets¥1.9bnat 2023-06-30StandaloneAssets
Total assets¥2.7bnat 2022-12-31StandaloneAssets
Total assets¥3.5bnat 2022-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥576mat 2023-06-30StandaloneLiabilities
Total liabilities¥492mat 2022-12-31StandaloneLiabilities
Net assets / equity¥1.3bnat 2023-06-30StandaloneNet assets
Net assets / equity¥2.2bnat 2022-12-31StandaloneNet assets
Net assets / equity¥2.7bnat 2022-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.3bnat 2023-06-30StandaloneCash and deposits
Cash and deposits¥1.7bnat 2022-12-31StandaloneCash and deposits
Cash & equivalents¥1.1bnat 2023-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.5bnat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥2.6bnat 2022-06-30StandaloneCash and cash equivalents
Cash & equivalents¥3.2bnat 2021-12-31dStandaloneCash and cash equivalents
Operating cash flow−¥452m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.7bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥722m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥748,0002023-01-01 → 2023-06-30StandaloneNet cash provided by used in investment activities
Investing cash flow¥20m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥21m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥45m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow−¥114m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥30m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-50.162023-01-01 → 2023-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-31.472023-04-01 → 2023-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-66.312022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-32.922022-01-01 → 2022-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-13.942022-04-01 → 2022-06-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio68.7%at 2023-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio81.2%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.9%at 2022-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued17,405,200at 2023-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued17,405,200at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued17,405,200at 2022-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 446
ItemContextValueUnit
Depreciation and amortization ope cfCurrentYTDDuration_NonConsolidatedMember141000JPY
Amortization of restricted stock remuneration ope cfPrior1YTDDuration_NonConsolidatedMember14289000JPY
Amortization of restricted stock remuneration ope cfCurrentYTDDuration_NonConsolidatedMember435000JPY
Gain on transfer of receivables ope cfPrior1YTDDuration_NonConsolidatedMember-21406000JPY
Gain on transfer of receivables ope cfCurrentYTDDuration_NonConsolidatedMember－JPY
Share based compensation expenses ope cfPrior1YTDDuration_NonConsolidatedMember41705000JPY
Share based compensation expenses ope cfCurrentYTDDuration_NonConsolidatedMember5488000JPY
Increase decrease in provision for retirement benefits ope cfPrior1YTDDuration_NonConsolidatedMember1792000JPY
Increase decrease in provision for retirement benefits ope cfCurrentYTDDuration_NonConsolidatedMember-153000JPY
Interest and dividends income ope cfPrior1YTDDuration_NonConsolidatedMember-287000JPY
Interest and dividends income ope cfCurrentYTDDuration_NonConsolidatedMember-536000JPY
Interest expenses ope cfPrior1YTDDuration_NonConsolidatedMember1937000JPY
Interest expenses ope cfCurrentYTDDuration_NonConsolidatedMember1781000JPY
Foreign exchange losses gains ope cfPrior1YTDDuration_NonConsolidatedMember-82550000JPY
Foreign exchange losses gains ope cfCurrentYTDDuration_NonConsolidatedMember-34696000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration_NonConsolidatedMember321697000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration_NonConsolidatedMember－JPY
Decrease increase in inventories ope cfPrior1YTDDuration_NonConsolidatedMember251000JPY
Decrease increase in inventories ope cfCurrentYTDDuration_NonConsolidatedMember15297000JPY
Decrease increase in prepaid expenses ope cfPrior1YTDDuration_NonConsolidatedMember-6679000JPY
Decrease increase in prepaid expenses ope cfCurrentYTDDuration_NonConsolidatedMember-1083000JPY
Decrease increase in accounts receivable other ope cfPrior1YTDDuration_NonConsolidatedMember-77824000JPY
Decrease increase in accounts receivable other ope cfCurrentYTDDuration_NonConsolidatedMember149396000JPY
Decrease increase in consumption taxes refund receivable ope cfPrior1YTDDuration_NonConsolidatedMember-21868000JPY
Decrease increase in consumption taxes refund receivable ope cfCurrentYTDDuration_NonConsolidatedMember54519000JPY
Decrease increase in advance payment ope cfPrior1YTDDuration_NonConsolidatedMember-68762000JPY
Decrease increase in advance payment ope cfCurrentYTDDuration_NonConsolidatedMember192523000JPY
Increase decrease in accounts payable other ope cfPrior1YTDDuration_NonConsolidatedMember-49980000JPY
Increase decrease in accounts payable other ope cfCurrentYTDDuration_NonConsolidatedMember31576000JPY
Increase decrease in contract liabilities ope cfPrior1YTDDuration_NonConsolidatedMember-151697000JPY
Increase decrease in contract liabilities ope cfCurrentYTDDuration_NonConsolidatedMember－JPY
Other net ope cfPrior1YTDDuration_NonConsolidatedMember-51383000JPY
Other net ope cfCurrentYTDDuration_NonConsolidatedMember5761000JPY
Subtotal ope cfPrior1YTDDuration_NonConsolidatedMember-719719000JPY
Subtotal ope cfCurrentYTDDuration_NonConsolidatedMember-446855000JPY
Interest and dividends income received ope cf inv cfPrior1YTDDuration_NonConsolidatedMember154000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration_NonConsolidatedMember243000JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration_NonConsolidatedMember-2189000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration_NonConsolidatedMember-2017000JPY
Income taxes paid ope cfPrior1YTDDuration_NonConsolidatedMember-728000JPY
Income taxes paid ope cfCurrentYTDDuration_NonConsolidatedMember-2923000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration_NonConsolidatedMember-722482000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration_NonConsolidatedMember-451552000JPY
Proceeds from selling credit inv cfPrior1YTDDuration_NonConsolidatedMember21406000JPY
Proceeds from selling credit inv cfCurrentYTDDuration_NonConsolidatedMember－JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration_NonConsolidatedMember-635000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration_NonConsolidatedMember-951000JPY
Proceeds from sales of property plant and equipment inv cfPrior1YTDDuration_NonConsolidatedMember－JPY
Proceeds from sales of property plant and equipment inv cfCurrentYTDDuration_NonConsolidatedMember136000JPY
Proceeds from collection of lease and guarantee deposits inv cfPrior1YTDDuration_NonConsolidatedMember71000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-06-30pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-06-30pass